Elio Adib

7PUBLICATIONS
64CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Molecular targetsPredictive and prognostic markersCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 24, 2026
Epigenetic Atlas of Bladder Cancer Reveals Master Transcription Factors and Risk-Associated Regulatory Elements in Luminal and Basal-Squamous Molecular Subtypes.

Elio Adib, Amin H Nassar, Sarah Abou Alaiwi

|Dec 19, 2025
Molecular and clinical insights of trastuzumab deruxtecan efficacy in advanced breast cancer.

Amin H Nassar, Elias Bou Farhat, Hassan Abushukair

|Mar 06, 2024
Clinical outcomes and safety of immune checkpoint inhibitors in patients with solid tumors and paraneoplastic syndromes.

Amin H Nassar, Talal El Zarif, Ahmed Bilal Khalid

|Nov 22, 2023
ATM deficiency confers specific therapeutic vulnerabilities in bladder cancer.

Yuzhen Zhou, Judit Börcsök, Elio Adib

|Jun 22, 2022
The Prostate Cancer Androgen Receptor Cistrome in African American Men Associates with Upregulation of Lipid Metabolism and Immune Response.

Jacob E Berchuck, Elio Adib, Sarah Abou Alaiwi

|Nov 02, 2021
Synergistic antitumor activity of pan-PI3K inhibition and immune checkpoint blockade in bladder cancer.

Shaoming Zhu, A-Hong Ma, Zheng Zhu

Pageof 2

Frequent Collaborators

4 joint publications

Amin Nassar

3 joint publications

Matthew L Freedman

3 joint publications

Toni K Choueiri

2 joint publications

Guru Sonpavde